Driessen, C.M.; Ham, J.C.; te Loo, M.; van Meerten, E.; van Lamoen, M.; Hakobjan, M.H.; Takes, R.P.; van der Graaf, W.T.; Kaanders, J.H.; Coenen, M.J.H.;
et al. Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study). Cancers 2019, 11, 551.
https://doi.org/10.3390/cancers11040551
AMA Style
Driessen CM, Ham JC, te Loo M, van Meerten E, van Lamoen M, Hakobjan MH, Takes RP, van der Graaf WT, Kaanders JH, Coenen MJH,
et al. Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study). Cancers. 2019; 11(4):551.
https://doi.org/10.3390/cancers11040551
Chicago/Turabian Style
Driessen, Chantal M., Janneke C. Ham, Maroeska te Loo, Esther van Meerten, Maurits van Lamoen, Marina H. Hakobjan, Robert P. Takes, Winette T. van der Graaf, Johannes H. Kaanders, Marieke J.H. Coenen,
and et al. 2019. "Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)" Cancers 11, no. 4: 551.
https://doi.org/10.3390/cancers11040551
APA Style
Driessen, C. M., Ham, J. C., te Loo, M., van Meerten, E., van Lamoen, M., Hakobjan, M. H., Takes, R. P., van der Graaf, W. T., Kaanders, J. H., Coenen, M. J. H., & van Herpen, C. M.
(2019). Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study). Cancers, 11(4), 551.
https://doi.org/10.3390/cancers11040551
